Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28173757)

Published in BMC Cardiovasc Disord on February 07, 2017

Authors

Núria Ribas1,2,3, Cosme García-García4,5, Oona Meroño4,6, Lluís Recasens4,6, Silvia Pérez-Fernández7,8, Víctor Bazán4, Neus Salvatella4,6, Julio Martí-Almor4,6, Jordi Bruguera4,6, Roberto Elosua7,8

Author Affiliations

1: Cardiology Department, Hospital del Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain. 60055@hospitaldelmar.cat.
2: Heart Diseases Biomedical Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. 60055@hospitaldelmar.cat.
3: Medicine Department, Program in Internal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. 60055@hospitaldelmar.cat.
4: Cardiology Department, Hospital del Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain.
5: Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
6: Heart Diseases Biomedical Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
7: IMIM (Hospital del Mar Medical Research Institute). Cardiovascular Epidemiology and Genetics Group (EGEC), REGICOR Study Group, Barcelona, Spain.
8: CIBER de Enfermedades Cardiovasculares (CIBERCV), Barcelona, Spain.

Articles cited by this

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J (2012) 13.74

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet (2009) 10.55

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94

Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet (2009) 5.84

Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study. Rev Esp Cardiol (Engl Ed) (2014) 2.66

Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med (2000) 2.30

MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado) study. General findings. Rev Esp Cardiol (2008) 2.09

[Primary percutaneous angioplasty. An analysis of reperfusion delays, their determining factors and their prognostic implications]. Rev Esp Cardiol (2009) 2.08

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol (2015) 1.57

[Reduction in acute myocardial infarction mortality over a five-year period]. Rev Esp Cardiol (2006) 1.57

Association between admission supine systolic blood pressure and 1-year mortality in patients admitted to the intensive care unit for acute chest pain. JAMA (2010) 1.49

[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41

Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation (2009) 1.36

Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J Am Coll Cardiol (2009) 1.12

Relation of early and one-year outcome after acute myocardial infarction to systemic arterial blood pressure on admission. Am J Cardiol (1999) 0.99

Which providers can bridge the health literacy gap in lifestyle risk factor modification education: a systematic review and narrative synthesis. BMC Fam Pract (2012) 0.94

Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study. Rev Esp Cardiol (Engl Ed) (2011) 0.90

Stable angina in Spain and its impact on quality of life. The AVANCE registry. Rev Esp Cardiol (Engl Ed) (2012) 0.89

The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Eur Heart J Acute Cardiovasc Care (2013) 0.88

Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007. Wien Klin Wochenschr (2010) 0.87

Impact on delay times and characteristics of patients undergoing primary percutaneous coronary intervention in the southern metropolitan area of Barcelona after implementation of the infarction code program. Rev Esp Cardiol (Engl Ed) (2012) 0.83

Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart (2005) 0.81

Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial. Circ Cardiovasc Interv (2014) 0.80

Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era. Scientifica (Cairo) (2016) 0.79

Systolic blood pressure on admission predicts in-hospital mortality among patients presenting with acute coronary syndromes: the Greek study of acute coronary syndromes. J Clin Hypertens (Greenwich) (2008) 0.79

Control of cardiovascular risk factors in revascularized patients with diabetes: a subanalysis of the ICP-Bypass study. Rev Esp Cardiol (Engl Ed) (2014) 0.78

Trends in in-hospital mortality and six-month outcomes in patients with a first acute myocardial infarction. Change over the last decade. Rev Esp Cardiol (2010) 0.77

Ischemic Stroke Risk After Acute Coronary Syndrome. J Am Heart Assoc (2016) 0.77

A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. Can J Cardiol (2016) 0.76

Clinical characteristics and short-term outcomes in patients with elevated admission systolic blood pressure after acute ST-elevation myocardial infarction: a population-based study. BMJ Open (2014) 0.76